MX2021011550A - Formulaciones de pregabalina y uso de las mismas. - Google Patents

Formulaciones de pregabalina y uso de las mismas.

Info

Publication number
MX2021011550A
MX2021011550A MX2021011550A MX2021011550A MX2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A
Authority
MX
Mexico
Prior art keywords
pregabalin
composition
animals
formulations
cats
Prior art date
Application number
MX2021011550A
Other languages
English (en)
Inventor
Mirja Huhtinen
Terttu Lamminen
Jukka Salmia
Johanna Tervapuro
Jurgen Vercruysse
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of MX2021011550A publication Critical patent/MX2021011550A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a una composición farmacéutica en forma de una composición líquida de administración oral que comprende pregabalina como principio activo y al uso de la misma en el tratamiento y la prevención de la ansiedad y el miedo al transporte y a la visita veterinaria en animales de compañía, como los gatos. La composición es estable, bien palatable para los animales y puede ser administrada fácilmente por el propietario de la mascota.
MX2021011550A 2019-03-26 2020-03-26 Formulaciones de pregabalina y uso de las mismas. MX2021011550A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20195226 2019-03-26
PCT/FI2020/050193 WO2020193864A1 (en) 2019-03-26 2020-03-26 Pregabalin formulations and use thereof

Publications (1)

Publication Number Publication Date
MX2021011550A true MX2021011550A (es) 2021-10-26

Family

ID=70292991

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011550A MX2021011550A (es) 2019-03-26 2020-03-26 Formulaciones de pregabalina y uso de las mismas.

Country Status (9)

Country Link
US (1) US20220175707A1 (es)
EP (1) EP3946260A1 (es)
JP (1) JP7500600B2 (es)
KR (1) KR20210143874A (es)
CN (1) CN113631150A (es)
AU (1) AU2020249679A1 (es)
CA (1) CA3131336A1 (es)
MX (1) MX2021011550A (es)
WO (1) WO2020193864A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2002002501A0 (en) 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
ATE334656T1 (de) 2001-05-25 2006-08-15 Warner Lambert Co Flüssige pharmazeutische zusammensetzung
EP1543831A1 (en) 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2009087682A2 (en) 2007-12-28 2009-07-16 Intas Pharmaceuticals Limited Stabilized injectable formulation of pregabalin

Also Published As

Publication number Publication date
EP3946260A1 (en) 2022-02-09
AU2020249679A1 (en) 2021-11-18
WO2020193864A1 (en) 2020-10-01
CN113631150A (zh) 2021-11-09
KR20210143874A (ko) 2021-11-29
US20220175707A1 (en) 2022-06-09
JP2022528520A (ja) 2022-06-14
JP7500600B2 (ja) 2024-06-17
CA3131336A1 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
WO2007122619A3 (en) Tto-based wide spectrum therapeutics, disinfectants & anesthetics for use in aquaculture
AR123902A2 (es) Composición veterinaria oral para el control de inapetencia para un gato o un perro
AR054987A1 (es) Composicion veterinaria trasmucosal
EA201270615A1 (ru) Противогрибковый препарат, содержащий грибковый организм
MX2019006773A (es) Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros.
ES2771599T3 (es) Composición tópica que comprende extractos de boldo y de reina de los prados, destinada a un animal, y sus aplicaciones
JPWO2014163030A1 (ja) 馬の炎症治療のための製剤
MX2021011550A (es) Formulaciones de pregabalina y uso de las mismas.
RU2016137926A (ru) Композиции грапипранта и способы их применения
MX2023010847A (es) Formulaciones de tasipimidina y uso de las mismas.
JP2008110929A (ja) 動物の外部寄生虫防除剤
Olson et al. The palatability and comparative efficacy of meloxicam oral suspension for the treatment of chronic musculoskeletal disease in horses
CN101869601B (zh) 一种外用兽药
Ramsey et al. Management of Addison's disease in dogs
MA41102A (fr) Compositions contenant de la curcumine à biodisponibilité améliorée
BR112016007057A2 (pt) um método veterinário para induzir êmese
Heinzl et al. Secondary plant compound to reduce the use of antibiotics
RU2021131027A (ru) Составы прегабалина и их применение
RU2612013C1 (ru) Антгельминтное средство для лечения и профилактики фасциолеза, дикроцелиоза и парамфистоматоза крупного рогатого скота
CN103550194A (zh) 一种外用兽药
Mingaleev et al. Application of the New Tuberculostatics-Linarol to Prevent Tuberculosis of Young Cattle under Farm
RU2008151796A (ru) Способ профилактики желудочно-кишечных заболеваний у поросят-отъемышей
Seksel Pheromones-what are they and how to use them effectively.
ES2472190A2 (es) Suspensión oleosa de metronidazol